Income Statement | | | | | | | | | | | | |
| | | | | | | | | | | | Original |
CNY | Fiscal Year Ending | | Latest |
(in millions) | | | | | | Dec-19 | Dec-20 | Dec-21 | Dec-22 | Dec-23 | | Sep-24 |
| FY - 9 | FY - 8 | FY - 7 | FY - 6 | FY - 5 | FY - 4 | FY - 3 | FY - 2 | FY - 1 | FY | | LTM |
| | | | | | | | | | | | |
Revenue | 0 | 0 | 0 | 0 | 0 | 3,880 | 11,336 | 20,121 | 24,221 | 19,971 | | 22,155 |
% Growth | NA | NA | NA | NA | NA | NA | 192.2% | 77.5% | 20.4% | -17.5% | | |
| | | | | | | | | | | | |
Cost of Revenue | 0 | 0 | 0 | 0 | 0 | (3,215) | (9,105) | (16,076) | (16,736) | (13,848) | | (15,467) |
Gross Profit | 0 | 0 | 0 | 0 | 0 | 665 | 2,230 | 4,045 | 7,486 | 6,123 | | 6,687 |
% Revenue | NA | NA | NA | NA | NA | 17.1% | 19.7% | 20.1% | 30.9% | 30.7% | | 30.2% |
| | | | | | | | | | | | |
Research and Development | 0 | 0 | 0 | 0 | 0 | (91) | (322) | (905) | (1,003) | (803) | | (790) |
Selling and Marketing | 0 | 0 | 0 | 0 | 0 | (260) | (569) | (1,515) | (541) | (393) | | (498) |
General and Admin | 0 | 0 | 0 | 0 | 0 | (2,055) | (4,502) | (7,977) | (6,693) | (5,060) | | (5,371) |
Other Inc / (Exp) | 0 | 0 | 0 | 0 | 0 | (99) | 8 | (28) | (7) | 2 | | 98 |
Total Operating Exp | 0 | 0 | 0 | 0 | 0 | (2,506) | (5,385) | (10,425) | (8,245) | (6,254) | | (6,561) |
| | | | | | | | | | | | |
Operating Income | 0 | 0 | 0 | 0 | 0 | (1,841) | (3,154) | (6,380) | (759) | (130) | | 126 |
% Revenue | NA | NA | NA | NA | NA | -47.4% | -27.8% | -31.7% | -3.1% | -0.7% | | 0.6% |
| | | | | | | | | | | | |
Interest Expense | 0 | 0 | 0 | 0 | 0 | (33) | (23) | (40) | (41) | 59 | | 97 |
Pre-tax Income | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,177) | (6,420) | (800) | (72) | | 223 |
Earnings of Discontinued Ops. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Provision for Taxes | 0 | 0 | 0 | 0 | 0 | 0 | 0 | (9) | (7) | (19) | | (15) |
Net Income to Company | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,177) | (6,429) | (807) | (91) | | 208 |
% Margin | NA | NA | NA | NA | NA | -48.3% | -28.0% | -32.0% | -3.3% | -0.5% | | 0.9% |
| | | | | | | | | | | | |
Minority Interest in Earnings | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | (0) |
Net Income to Stockholders | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,177) | (6,429) | (807) | (91) | | 208 |
| | | | | | | | | | | | |
Preferred Dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Other Adj. | 0 | 0 | 0 | 0 | 0 | (121) | (320) | (288) | (7) | (9) | | (10) |
| | | | | | | | | | | | |
Net Income to Common | 0 | 0 | 0 | 0 | 0 | (1,994) | (3,497) | (6,717) | (814) | (100) | | 198 |
% Margin | NA | NA | NA | NA | NA | -51.4% | -30.9% | -33.4% | -3.4% | -0.5% | | 0.9% |
| | | | | | | | | | | | |
As Reported | | | | | | | | | | | | |
Basic EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (48.68) | (82.36) | (51.75) | (3.77) | (0.46) | | 0.92 |
Diluted EPS (Continuing Ops) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | (48.68) | (82.36) | (51.75) | (3.77) | (0.46) | | 0.92 |
| | | | | | | | | | | | |
WA Basic Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.96 | 42.46 | 129.81 | 216.22 | 216.65 | | 216.73 |
WA Diluted Shares Out. | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 40.96 | 42.46 | 129.81 | 216.22 | 216.65 | | 219.20 |
| | | | | | | | | | | | |
EBITDA, EBIT Reconciliation | | | | | | | | | | | | |
EBT, Incl. Unusual Items | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,177) | (6,420) | (800) | (72) | | 223 |
Addback: Net Interest Expense | 0 | 0 | 0 | 0 | 0 | 33 | 23 | 40 | 41 | (59) | | (97) |
Addback: Other Non Operating Expenses, Total | 0 | 0 | 0 | 0 | 0 | 99 | (5) | 11 | (40) | 0 | | 5 |
Addback: Depreciation & Amortization | 0 | 0 | 0 | 0 | 0 | 35 | 115 | 213 | 204 | 155 | | 118 |
Addback: Restructuring Charges | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Merger / Acquisition Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Goodwill Impairment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Invest. | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Gain (Loss) On Sale Of Assets | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 35 | 67 | 41 | | 41 |
Addback: Asset Writedown | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: In Process R&D Expenses | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Insurance Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Legal Settlements | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Addback: Other Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | | 0 |
Adjusted EBITDA | 0 | 0 | 0 | 0 | 0 | (1,707) | (3,028) | (6,120) | (528) | 66 | | 290 |
% Margin | NA | NA | NA | NA | NA | -44.0% | -26.7% | -30.4% | -2.2% | 0.3% | | 1.3% |
| | | | | | | | | | | | |
Adjusted EBIT | 0 | 0 | 0 | 0 | 0 | (1,741) | (3,143) | (6,333) | (733) | (89) | | 172 |
% Margin | NA | NA | NA | NA | NA | -44.9% | -27.7% | -31.5% | -3.0% | -0.4% | | 0.8% |
| | | | | | | | | | | | |
Adjusted Net Income Reconciliation | | | | | | | | | | | | |
Net Income to Company | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,177) | (6,429) | (807) | (91) | | 208 |
Addback: Unusual Items | 0 | 0 | 0 | 0 | 0 | 0 | 16 | 35 | 67 | 41 | | 41 |
Less: Tax Benefit of Unusual Items (26%) | 0 | 0 | 0 | 0 | 0 | 0 | (4) | (9) | (17) | (11) | | (11) |
Adjusted Net Income | 0 | 0 | 0 | 0 | 0 | (1,873) | (3,165) | (6,403) | (757) | (61) | | 239 |
% Margin | NA | NA | NA | NA | NA | -48.3% | -27.9% | -31.8% | -3.1% | -0.3% | | 1.1% |